Persistence with denosumab and persistence with oral bisphosphonates for the treatment of postmenopausal osteoporosis: a retrospective, observational study, and a meta-analysis

被引：0
|
作者：
L. Karlsson
J. Lundkvist
E. Psachoulia
M. Intorcia
O. Ström
机构：
[1] Quantify Research,Department of Learning, Informatics, Management and Ethics (LIME), Medical Management Centrum (MMC)
[2] Karolinska Institutet,Department of Pharmacy
[3] Uppsala University,undefined
[4] Amgen (Europe) GmbH,undefined
来源：
Osteoporosis International | 2015年 / 26卷
关键词：
Bisphosphonates; Denosumab; Meta-analysis; Persistence; Retrospective; Review;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2401 / 2411
页数：10
相关论文
共 50 条
  • [21] Persistence at 12 months with denosumab in postmenopausal women with osteoporosis: interim results from a prospective observational study
    S. L. Silverman
    E. Siris
    D. L. Kendler
    D. Belazi
    J. P. Brown
    D. T. Gold
    E. M. Lewiecki
    A. Papaioannou
    C. Simonelli
    I. Ferreira
    A. Balasubramanian
    P. Dakin
    P. Ho
    S. Siddhanti
    B. Stolshek
    C. Recknor
    Osteoporosis International, 2015, 26 : 361 - 372
  • [22] Comparison of denosumab and oral bisphosphonates for the treatment of glucocorticoid-induced osteoporosis: a systematic review and meta-analysis
    Lianghai Jiang
    Jian Dong
    Jianwei Wei
    Lantao Liu
    BMC Musculoskeletal Disorders, 23
  • [23] Comparison of denosumab and oral bisphosphonates for the treatment of glucocorticoid-induced osteoporosis: a systematic review and meta-analysis
    Jiang, Lianghai
    Dong, Jian
    Wei, Jianwei
    Liu, Lantao
    BMC MUSCULOSKELETAL DISORDERS, 2022, 23 (01)
  • [24] Osteoporosis treatment preferences and satisfaction in postmenopausal women: Denosumab compared with oral bisphosphonates
    Bajger, Boguslawa
    AUSTRALIAN JOURNAL OF ADVANCED NURSING, 2018, 35 (03) : 39 - 49
  • [25] Efficacy of the Combination of Teriparatide and Denosumab in the Treatment of Postmenopausal Osteoporosis: A Meta-Analysis
    Sun, Yang
    Li, Yue
    Li, Jiangbi
    Xie, Xiaoping
    Gu, Feng
    Sui, Zhenjiang
    Zhang, Ke
    Yu, Tiecheng
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [26] PERSISTENCE & COMPLIANCE TO TREATMENT FOR OSTEOPOROSIS IN POSTMENOPAUSAL WOMEN IN HUNGARY: A RETROSPECTIVE COHORT STUDY
    Lakatos, P.
    Toth, E.
    Cina, Z.
    Lang, Z.
    Psachoulia, E.
    Intorcia, M.
    VALUE IN HEALTH, 2013, 16 (07) : A567 - A568
  • [27] PERSISTENCE & COMPLIANCE TO TREATMENT FOR OSTEOPOROSIS IN POSTMENOPAUSAL WOMEN IN HUNGARY: A RETROSPECTIVE COHORT STUDY
    Lakatos, Peter
    Toth, Emese
    Kovacs, Eszter
    Lang, Zsolt
    Psachoulia, Emi
    Intorcia, Michele
    OSTEOPOROSIS INTERNATIONAL, 2013, 24 : S196 - S196
  • [28] A RETROSPECTIVE COHORT STUDY OF PERSISTENCE & COMPLIANCE TO TREATMENT FOR OSTEOPOROSIS IN POSTMENOPAUSAL WOMEN IN HUNGARY
    Lakatos, P.
    Toth, E.
    Kovacs, E.
    Lang, Z.
    Psachoulia, E.
    Intorcia, M.
    VALUE IN HEALTH, 2012, 15 (07) : A449 - A449
  • [29] A Meta-Analysis of 4 Clinical Trials of Denosumab Compared with Bisphosphonates in Postmenopausal Women Previously Treated with Oral Bisphosphonates
    Miller, Paul D.
    Pannacciulli, N.
    Malouf, J.
    Singer, A.
    Czerwinski, E.
    Bone, H. G.
    Wang, C.
    Wagman, Rachel B.
    Brown, J. P.
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [30] Persistence At 12 Months With Denosumab (Prolia®) In Postmenopausal Women With Osteoporosis: Interim Results From a Prospective Observational Study
    Silverman, Stuart L.
    Siris, Ethel
    Kendler, David L.
    Belazi, Dea
    Brown, Jacques P.
    Gold, Deborah T.
    Lewiecki, E. Michael
    Papaioannou, Alexandra
    Simonelli, Christine
    Ferreira, Irene
    Dakin, Paula
    Siddhanti, Suresh
    Stolshek, Bradley
    Recknor, Christopher
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S523 - S523
12345